Discovery of a putative blood-based protein signature associated with response to ALK tyrosine kinase inhibition.
Couëtoux du Tertre M, Marques M, McNamara S, Gambaro K, Hoffert C, Tremblay L, Bouchard N, Diaconescu R, Blais N, Couture C, Pelsser V, Wang H, McIntosh L, Hindie V, Parent S, Cortes L, Breton YA, Pottiez G, Croteau P, Higenell V, Izzi L, Spatz A, Cohen V, Batist G, Agulnik J.
Couëtoux du Tertre M, et al. Among authors: mcnamara s.
Clin Proteomics. 2020 Feb 7;17:5. doi: 10.1186/s12014-020-9269-6. eCollection 2020.
Clin Proteomics. 2020.
PMID: 32055239
Free PMC article.
Several proteins were identified as differentially expressed between long-term responders and poor responders, including DPP4, KIT and LUM. ...Registered 22 January 2014, https://clinicaltrials.gov/ct2/show/NCT02041468?term=NCT02041468&rank=1....
Several proteins were identified as differentially expressed between long-term responders and poor responders, including DPP4, KIT an …